Milestone Scientific to Present at the Edgewater Research Investor Conference
EdgeWater Research Partners, LLC is an independent micro cap equitiesresearch company representing the research of David Lavigne. EdgeWaterfollows a number of undiscovered small and micro cap stocks through bothindividual research and its monthly publication, The EdgeWater Micro Monthly.EdgeWater's research is distributed to its subscriber base, and is alsoavailable on a piece by piece basis on the Company's website,http://www.edgewaterresearch.com.
About Milestone Scientific, Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engagedin pioneering proprietary, highly innovative technological solutions for themedical and dental markets. Central to the Company's IP platform and productdevelopment strategy is its patented CompuFlo(TM) technology for the improvedand painless delivery of local anesthetic. Specifically, CompuFlo is acomputer-controlled, pressure sensitive infusion, perfusion, suffusion andaspiration technology, which provides real-time readouts of pressures, fluiddensities and flow rates, enabling the advanced delivery and removal of a widearray of fluids. The STA(TM) System, a computer-controlled local anesthesiadelivery system which uses this technology provides dentists with audible andvisual signals as to in-tissue pressure. Milestone's existing painlessinjection systems are currently sold in 25 countries. For more information onthese and other innovative Milestone products, please visit the Company's website found at http://www.milesci.com.
Safe Harbor Statement:
This press release contains forward-looking statements regarding thetiming and financial impact of the Milestone's ability to implement itsbusiness plan, expected revenues and future success. These statements involvea number of risks and uncertainties and are based on assumptions involvingjudgments with respect to future economic, competitive and market conditionsand future business decisions, all of which are difficult or impossible topredict accurately and many of which are beyond Milestone's control. Some ofthe important factors that could cause actual results to differ materiallyfrom those indicated by the forward-looking statements are general economicconditions, failure to achieve expected revenue growth, changes in ouroperating expenses, adverse patent rulings, FDA or legal developments,competitive pressures, changes in customer and market requirements andstandards, and the risk factors detailed from time to time in Milestone'speriodic filings with the Securities and Exchange Commission, includingwithout limitation, Milestone's Annual Report on Form 10-KSB for the yearended December 31, 2006. The forward looking-statements in this press releaseare based upon management's reasonable belief as of the date hereof. Milestoneundertakes no obligation to revise or update publicly any forward-lookingstatements for any reason.WHO: Leonard Osser, Chairman and CEO, Milestone Scientific Joe Martin, CEO, Milestone Medical WHEN: Wednesday, October 10, 2007 at 8:50 AM MDT WHERE: Loews Ventana Canyon Resort 7000 North Resort Drive Tucson, AZ 85750
SOURCE Milestone Scientific, Inc.
You May Also Like